Article Versions Notes

Fragkiadakis K, Ktena N, Kalantidou A, Dermitzaki E, Anastasiou I, Papathanasiou S, Kontaraki J, Kalomoirakis P, Kanoupakis E, Patrianakos A, et al. Cytokeratin 18 as a Novel Biomarker in Patients with Hypertrophic Cardiomyopathy. Cells. 2024; 13(16):1328. https://doi.org/10.3390/cells13161328

Fragkiadakis, Konstantinos, Niki Ktena, Aikaterini Kalantidou, Eirini Dermitzaki, Ioannis Anastasiou, Stamatis Papathanasiou, Joanna Kontaraki, Petros Kalomoirakis, Emmanuel Kanoupakis, Alexandros Patrianakos, and et al. 2024. "Cytokeratin 18 as a Novel Biomarker in Patients with Hypertrophic Cardiomyopathy" Cells 13, no. 16: 1328. https://doi.org/10.3390/cells13161328

Fragkiadakis, K., Ktena, N., Kalantidou, A., Dermitzaki, E., Anastasiou, I., Papathanasiou, S., Kontaraki, J., Kalomoirakis, P., Kanoupakis, E., Patrianakos, A., Papadomanolakis, A., Daskalaki, E., Kiousi, T., Kouraki, K., Kranioti, E., Tzardi, M., Venihaki, M., Karagogeos, D., Capetanaki, Y., ... Marketou, M. (2024). Cytokeratin 18 as a Novel Biomarker in Patients with Hypertrophic Cardiomyopathy. Cells, 13(16), 1328. https://doi.org/10.3390/cells13161328